2nd Quarter - Report
BROWNSTEIN HYATT FARBER SCHRECK, LLP for ROMARK GLOBAL PHARMA, LLC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Client
Income
$60,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 19, 2023 | $60,000 | Replaced |
| 2nd Quarter - Amendment | Jul 19, 2023 | $40,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Issues regarding Biomedical Advanced Research and Development Authority Covid-19 Therapeutics' Pandemic All Hazards Prepardness Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURA JOHNSON BOLLIER | — |
| EMILY FELDER | — |
| SOHIL KHURANA | — |
| EDWARD RANDALL ROYCE | — |
| ADAM STEINMETZ | — |
| GREGORY SUNSTRUM New | Chief of Staff , Rep. Debbie Dingell; Deputy Chief of Staff and Leg. Director, Rep. Debbie Dingell ; Leg. Director, Rep. John Dingell; Leg. Assistant, Rep. John Dingell; Staff Assistant/Leg. Correspondent Rep. John Dingell |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.